💡 Did you know?
The BSE, founded in 1875, is Asia's oldest stock exchange — it started under a banyan tree on Dalal Street, where the bronze bull stands today.
History
The BSE, founded in 1875, is Asia's oldest stock exchange — it started under a banyan tree on Dalal Street, where the bronze bull stands today.
The BSE, founded in 1875, is Asia's oldest stock exchange — it started under a banyan tree on Dalal Street, where the bronze bull stands today.
Tatva Chintan Pharma Chem Limited is an India-based specialty chemical manufacturing company. The Company is engaged in the manufacturing of a variety of chemicals, including structure directing agents (SDAs), phase transfer catalysts (PTCs), electrolyte salts and solutions…
Weekly engine runs — movement reflects the numbers, not analyst opinion.
A middling, stagnant business, fully valued.
Tatva Chintan Pharma Chem is scored on the general / industrial framework. It keeps a slim 8.3% of every rupee of sales as net profit. Cash conversion lags the reported profit (CFO/PAT 0.75×) — worth a closer look. Free cash flow is worth about -2.3% of its market value.
Over the last 3 years revenue compounded at 6%/yr and profit at -3%/yr. Book value has grown 15%/yr. Return on equity is a weak 7.7%. In the latest quarter profit grew 34% versus the prior quarter.
At 89× earnings, the stock sits at the 67th percentile of its own 3.3-year range — the middle of where it has historically traded. Today's price already implies ~24%/yr earnings growth sustained for a decade — a demanding bar. The books come through clean — a forensic grade of A, and Altman puts distress risk in the safe zone.
A plain-English restatement of the figures on this page — rules-based, for education and research context, not investment advice or a recommendation.
| Ratio | Company | Sector | Read |
|---|---|---|---|
| P/E | 59.58 | — | — |
| P/B | 4.6 | 2.66 | worse |
| EV/EBITDA | 30.88 | 9.95 | worse |
| ROE | 7.72 | — | — |
| ROCE | 9.23 | — | — |
| ROA | 5.62 | — | — |
| Quick Ratio | 0.72 | 2.26 | worse |
| Peer | P/E | P/B | ROE |
|---|---|---|---|
| Pidilite Industries | 59.1 | 14.3 | 23.9% |
| SRF | 32.3 | 4.8 | 14.9% |
| Linde India | 118.3 | 13.3 | 11.3% |
6% CAGR — growing but slowly. Growth is accelerating — latest year outpaced the prior year's rate.
Revenue is outpacing profit (6% vs -3%) — costs are rising faster than the top line. The latest year saw a +636% swing — check if it's a one-off or structural.
Operating margins have been stable around 11% — no major structural shift. The gap between operating and net margin is widening — interest or tax costs are rising.
ROE at 5% — modest; the capital isn't working hard.
-4% EPS CAGR — this is the rate at which each share's claim on earnings is compounding.
Operating cash flow has been positive every year — the business generates real cash, not just accounting profit. Investing outflows exceed operating cash — the company relies on external funding to finance expansion. Raising capital despite positive cash flow — could signal expansion plans or opportunistic fundraising.
When operating cash keeps pace with reported profit, earnings are cash-backed; a persistent shortfall is a quality flag.
Revenue rose 29% sequentially — momentum is building. Wide quarterly swings (39% spread) — likely seasonality, lumpy orders, or project-based revenue. Run-rate stepping up — recent quarters average 46% above earlier ones.
Profit jumped 34% QoQ — check if this is operating leverage or a one-off item.
How today's P/E compares to the stock's own historical range. Dashed line = the 3.3y median.
Promoters hold 72.0% — heavily owner-operated with strong skin in the game.
Produced by a rules-based engine over licensed exchange fundamentals — every sentence above is derived from the numbers shown, no analyst or AI opinion involved. Education and research context, not investment advice. We are not SEBI-registered as an Investment Adviser or Research Analyst.